Lijun Dong

465 citations
18 papers · 352 indexed · 1 hit paper · h-index 9

Lijun Dong

18 papers receiving 349 citations

Hit Papers

Mannose ameliorates experimental colitis by protecting in...168202220262023202450100150

Peers

Lijun Dong
Comparison fields: 5 of 80
  • Neurology 35
  • Immunology 68
  • Biological Psychiatry 8
  • Pharmacology 24
  • Nutrition and Dietetics 39
Replace Wenwen Cui with:
Wenwen Cui China
Fengying Xu China
Adam Kim United States
Kwame Oteng Darko China
Shaowei Huang China
Yanfang Wu China
Zhengnan Ren China
C Kunst Germany
Chenyang Li China
Shuodong Wu China
Lijun Dong relative to Wenwen Cui China Wenwen Cui's profile →
Citations per field
00.5×1.5×
Wenwen Cui · 1×
Citations per year

Countries citing papers authored by Lijun Dong

Since Specialization
Citations

This map shows the geographic impact of Lijun Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Dong more than expected).

Fields of papers citing papers by Lijun Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Dong. The network helps show where Lijun Dong may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lijun Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lijun Dong Line = papers co-authored together Lijun Dong links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20241
2 20236
3 20236
4 20222
5
Mannose ameliorates experimental colitis by protecting intestinal barrier integritybreakdown →
2022168
6 202232
7 20225
8 20229
9 202126
10 20217
11 20212
12 202018
13 20207
14 201913
15 201915
16 201922
17
Cloning and expression analysis of the Dscam gene during the inducing immune priming (Quasi-immune) response in Fenneropenaeus chinensis.
20183
18 201710

About Lijun Dong

Lijun Dong is a scholar working on Neurology, Immunology and Pharmacology, having authored 18 papers that have together received 352 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (3 papers), Gut microbiota and health (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Immune Cell Function and Interaction (2 papers), Adipose Tissue and Metabolism (2 papers), Alcohol Consumption and Health Effects (2 papers), Barrier Structure and Function Studies (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Neurology (35 citations), Immunology (68 citations) and Biological Psychiatry (8 citations). Lijun Dong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Daming Zuo, Jia Zhou, Zhengliang Chen, Yunzhi Liu, Jingwen Xie, Youyi Wang, Liyun Zhang, Dantong Li, Kai Chen and Qingqing Wang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026